BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2716670)

  • 1. Drug advertising.
    Moulds RF; Wing LM
    Med J Aust; 1989 Apr; 150(7):410-1. PubMed ID: 2716670
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug advertising.
    Med J Aust; 1987 Jun; 146(12):660-1. PubMed ID: 3626920
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceutical promotion.
    Harvey K
    Med J Aust; 1990 Jan; 152(2):57-8. PubMed ID: 2296230
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Assessment of advertising.
    Wigle WW
    Can Med Assoc J; 1974 Apr; 110(7):759. PubMed ID: 4825144
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug advertising.
    Bell KD
    Med J Aust; 1987 Oct; 147(7):361. PubMed ID: 3657662
    [No Abstract]   [Full Text] [Related]  

  • 6. The Food and Drug Administration's regulation of drug labeling, advertising, and promotion: looking back and looking ahead.
    Hayes TA
    Clin Pharmacol Ther; 1998 Jun; 63(6):607-16. PubMed ID: 9663174
    [No Abstract]   [Full Text] [Related]  

  • 7. Can drug companies have it both ways?
    Rapp MS
    CMAJ; 1997 Apr; 156(7):982-3. PubMed ID: 9099165
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug marketing practices criticized.
    Wagner L
    Mod Healthc; 1990 Dec; 20(50):12. PubMed ID: 10108088
    [No Abstract]   [Full Text] [Related]  

  • 9. "Ethical" drugs.
    Rivin AU
    Pharos Alpha Omega Alpha Honor Med Soc; 1980; 43(2):9-10. PubMed ID: 7384207
    [No Abstract]   [Full Text] [Related]  

  • 10. PAAB: a lesson in self-government.
    Lexchin J
    CMAJ; 1991 Apr; 144(7):844-5. PubMed ID: 2007233
    [No Abstract]   [Full Text] [Related]  

  • 11. Traveling medicine shows: a modern update?
    Carroll-Johnson RM
    Oncol Nurs Forum; 1992 Oct; 19(9):1315. PubMed ID: 1437666
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulating pharmaceutical advertising: what will work?
    Shapiro MF
    CMAJ; 1997 Feb; 156(3):359-61. PubMed ID: 9033416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Questions timing of publicity on new drug.
    Dorsey M
    J Am Vet Med Assoc; 1999 Mar; 214(5):623-4. PubMed ID: 10088006
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug ads: how much is hype?
    Johns Hopkins Med Lett Health After 50; 2001 Nov; 13(9):1-2. PubMed ID: 11682901
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmaceutic promotion and publicity: quo vadis?].
    Castillo PĂ©rez P
    Med Clin (Barc); 1992 Sep; 99(8):305-9. PubMed ID: 1453825
    [No Abstract]   [Full Text] [Related]  

  • 16. Monitoring pharmaceutical company promotions.
    Gillette RD
    Fam Med; 1991 Feb; 23(2):92. PubMed ID: 2037220
    [No Abstract]   [Full Text] [Related]  

  • 17. Direct-to-consumer advertising: education or anathema?
    Rosner F; Kark P; Packer S; Bennett A; Berger J
    JAMA; 1999 Oct; 282(13):1227; author reply 1227-8. PubMed ID: 10517421
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug company accused of breaking advertising regulations.
    Waechter F
    BMJ; 2003 May; 326(7399):1106. PubMed ID: 12763970
    [No Abstract]   [Full Text] [Related]  

  • 19. [Masked emotions and depressions].
    Zahle V
    Ugeskr Laeger; 1970 Dec; 132(49):2355-7. PubMed ID: 5530668
    [No Abstract]   [Full Text] [Related]  

  • 20. Standards for pharmaceutical advertising in Canada.
    Chepesiuk R
    CMAJ; 2005 Aug; 173(3):238; author reply 238. PubMed ID: 16076811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.